Intelligence Β· Clinical Pipeline

Teva Pharma Pipeline

All ClinicalTrials.gov programs at Teva Pharma β€” phase, modality, and trial IDs.

Programs
148

Quick answer

Teva Pharma has 148 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. pagoclone

    Teva Pharma GmbH

    Stuttering

    phase 3 small molecule completed

    1 trial
  2. rasagiline

    Teva Pharma GmbH

    Restless Legs Syndrome

    phase 3 small molecule terminated

    1 trial
  3. reslizumab

    Teva Pharma GmbH

    Eosinophilic Esophagitis

    phase 3 small molecule completed

    2 trials
  4. reslizumab

    Teva Pharma GmbH

    Eosinophils, Asthma

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

How many pipeline programs does Teva Pharma have?

148 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs